SCHEDULE: Vanguard Group Amends Exact Sciences Ownership to 0%

The Vanguard Group filed an amendment to its Schedule 13G for Exact Sciences Corp, reporting 0% beneficial ownership due to an internal reporting realignment.

Summary

• The Vanguard Group filed an Amendment No. 12 to its Schedule 13G regarding its beneficial ownership in Exact Sciences Corp.
• The filing reports that The Vanguard Group now beneficially owns 0.00 shares, representing 0% of the class of Common Stock.
• This change is a result of an internal realignment within The Vanguard Group, effective January 12, 2026.
• Following the realignment, certain subsidiaries or business divisions of Vanguard will now report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc.
• These subsidiaries and/or business divisions continue to pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment.
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by these subsidiaries and/or business divisions.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative update. The change to 0% beneficial ownership by The Vanguard Group is due to an internal reporting realignment, not a divestment, suggesting no direct positive or negative sentiment towards Exact Sciences Corp's performance or prospects.

Future Outlook

No forward-looking statements or guidance for Exact Sciences Corp are provided in this administrative filing.

Management Comments

• On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment.
• In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release.
• These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment.
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.

Industry Context

StockSavvy.ai notes that this filing reflects an administrative change in how a major institutional investor, The Vanguard Group, reports its beneficial ownership, rather than a strategic investment decision related to the healthcare or diagnostics industry where Exact Sciences operates. Such internal realignments are common for large asset managers and typically do not signal a change in investment thesis for the underlying holdings.

Stakeholder Impact

• Shareholders of Exact Sciences Corp: Minimal direct impact, as the underlying investment by Vanguard-affiliated entities likely continues, just reported differently. No change in the company's fundamentals is implied.
• The Vanguard Group: This reflects an internal operational change in reporting structure.

Key Dates

Keywords

Exact Sciences Corp, Vanguard Group, Schedule 13G, Beneficial Ownership, SEC Filing, Institutional Investor, Ownership Change, Internal Realignment